Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Duncan Charles Cliff — Vanda Pharmaceuticals Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Duncan Charles Cliff

Duncan Charles Cliff

Director at Vanda Pharmaceuticals Inc. · on record since Apr 24, 2026

Insider trading activity of Duncan Charles Cliff

Transactions on record: 2; since Apr 24, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 8, 2026

Figures computed from official regulatory filings — methodology.

Companies where Duncan Charles Cliff has traded

Vanda Pharmaceuticals Inc.2 tx · Jun 8, 2026

Track record of Duncan Charles Cliff

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Duncan Charles Cliff

Co-insiders of Duncan Charles Cliff

BARKAS ALEXANDER EVanda Pharmaceuticals Inc.
Baroldi PaoloVanda Pharmaceuticals Inc.
BATE KENNETHVanda Pharmaceuticals Inc.
Biomedical Sciences Investment Fund Pte Ltd.Vanda Pharmaceuticals Inc.
Bio One Capital Pte Ltd.Vanda Pharmaceuticals Inc.
Birznieks GuntherVanda Pharmaceuticals Inc.
BLAIR JAMES CVanda Pharmaceuticals Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CARE CAPITAL II LLCVanda Pharmaceuticals Inc.

CARE CAPITAL INVESTMENTS II LPVanda Pharmaceuticals Inc.

Care Capital Offshore Investments II LPVanda Pharmaceuticals Inc.

Chrousos PhaedraVanda Pharmaceuticals Inc.

Clark William DVanda Pharmaceuticals Inc.

COLA MICHAEL FVanda Pharmaceuticals Inc.

Copmann Thomas LyleVanda Pharmaceuticals Inc.

Domain Partners VI, L.P.Vanda Pharmaceuticals Inc.

DOVEY BRIAN HVanda Pharmaceuticals Inc.

DP VI Associates, L.P.Vanda Pharmaceuticals Inc.

DUGAN RICHARD WVanda Pharmaceuticals Inc.

EDB Investments Pte Ltd.Vanda Pharmaceuticals Inc.

Feeney John JosephVanda Pharmaceuticals Inc.

Galson Steven KVanda Pharmaceuticals Inc.

Gianchetti Albert W.Vanda Pharmaceuticals Inc.

Gibbs Thomas EdwardVanda Pharmaceuticals Inc.

Gulino Richard L.Vanda Pharmaceuticals Inc.

Halak Brian KVanda Pharmaceuticals Inc.

HIRSCH RUSSELL CVanda Pharmaceuticals Inc.

HOCKMEYER WAYNE TVanda Pharmaceuticals Inc.

Honore TageVanda Pharmaceuticals Inc.

Howell Scott LaverneVanda Pharmaceuticals Inc.

Irish Stephanie RastVanda Pharmaceuticals Inc.

Jones Aranthan IIVanda Pharmaceuticals Inc.

KAIROUZ HABIBVanda Pharmaceuticals Inc.

KARABELAS ARGERIS NVanda Pharmaceuticals Inc.

Kelly James PatrickVanda Pharmaceuticals Inc.

LESCHLY JANVanda Pharmaceuticals Inc.

LESCHLY MARKVanda Pharmaceuticals Inc.

McGuire Daniel PatrickVanda Pharmaceuticals Inc.

MEDIMMUNE INC /DEVanda Pharmaceuticals Inc.

MILANO VINCENTVanda Pharmaceuticals Inc.

Mitchell Stephen RayVanda Pharmaceuticals Inc.

Moran Kevin PatrickVanda Pharmaceuticals Inc.

MORE ROBERT JVanda Pharmaceuticals Inc.

Phadke Deepak ShripadVanda Pharmaceuticals Inc.

PIEN HOWARD HVanda Pharmaceuticals Inc.

Polymeropoulos Christos Vasilios MihaelVanda Pharmaceuticals Inc.

Polymeropoulos Mihael HristosVanda Pharmaceuticals Inc.

PROSPECT ASSOCIATES II L PVanda Pharmaceuticals Inc.

PROSPECT MANAGEMENT CO II LLCVanda Pharmaceuticals Inc.

PROSPECT VENTURE PARTNERS II LPVanda Pharmaceuticals Inc.

Ramsay David RussVanda Pharmaceuticals Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Vanda Pharmaceuticals Inc.	Jun 8, 2026	Award	41,600	0.00 USD	$0	SEC
Vanda Pharmaceuticals Inc.	Apr 24, 2026	Award	57,101	0.00 USD	$0	SEC